PRKAA1 and atherosclerosis: While we have taken yet another approach to assessing the contribution of AMPK to atherogenesis (PCSK9-induced atherosclerosis and deletion of both myeloid AMPKα1 and AMPKα2), future work should concentrate on dissecting the specific molecular and metabolic pathways by which this important regulator may act.